Viewing Study NCT05218603

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-05-21 @ 9:02 AM
Study NCT ID: NCT05218603
Status: UNKNOWN
Last Update Posted: 2022-09-16
First Post: 2022-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT
Sponsor: PETHEMA Foundation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Non-eligible for Autologous Stem Cell Transplantation (ASCT) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prospective View
None Observational study View
None Multiple Myeloma View